Article: UK's NICE issues chronic hand eczema appraisal doc.

The National Institute for Health and Clinical Excellence (NICE), which determines which drugs should be covered by the UK National Health Service outside Scotland, has issued its preliminary recommendation in favor of Swiss drugmaker Basilea Pharmaceutica's Toctino (alitretinoin) for patients with chronic hand eczema. The Institute proposes that the agent be used once-a day for adults with the condition who ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!